BioXcel Therapeutics
(NASDAQ:BTAI)
$14.9679
-0.0321[-0.21%]
Last update: 1:25PM
Day High/Low14.8 - 15.67
52 Week High/Low8.8 - 24.57
Open / Close15.06 / -
Float / Outstanding14.8M / 28M
Vol / Avg.265.8K / 539.2K
Mkt Cap418.9M
P/E-
50d Avg. Price13.78
Div / Yield-
Payout Ratio-
EPS-1.12
Total Float14.8M

BioXcel Therapeutics (NASDAQ:BTAI), Quotes and News Summary

BioXcel Therapeutics (NASDAQ: BTAI)

Day High/Low14.8 - 15.67
52 Week High/Low8.8 - 24.57
Open / Close15.06 / -
Float / Outstanding14.8M / 28M
Vol / Avg.265.8K / 539.2K
Mkt Cap418.9M
P/E-
50d Avg. Price13.78
Div / Yield-
Payout Ratio-
EPS-1.12
Total Float14.8M
Sector: Health Care.Industry: Biotechnology
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q2 2022Est.ActualSurprise
EPS-1.220-1.350 -0.1300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

BioXcel Therapeutics Questions & Answers

Q
How do I buy BioXcel Therapeutics (BTAI) stock?
A

You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are BioXcel Therapeutics's (BTAI) competitors?
Q
What is the target price for BioXcel Therapeutics (BTAI) stock?
A

The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by Mizuho on Thursday, July 7, 2022. The analyst firm set a price target for 19.00 expecting BTAI to rise to within 12 months (a possible 26.94% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for BioXcel Therapeutics (BTAI)?
A

The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $14.9679 last updated Today at August 11, 2022, 5:25 PM UTC.

Q
Does BioXcel Therapeutics (BTAI) pay a dividend?
A

There are no upcoming dividends for BioXcel Therapeutics.

Q
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
A

BioXcel Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q
Is BioXcel Therapeutics (BTAI) going to split?
A

There is no upcoming split for BioXcel Therapeutics.

Q
What sector and industry does BioXcel Therapeutics (BTAI) operate in?
A

BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.